Endocrine Oncology
Research activity includes adrenocortical carcinoma, with interest in postoperative treatment strategies for high-risk disease and recurrence prevention after surgical resection.
- Adrenocortical carcinoma
- Adjuvant therapy
- Recurrence-free survival
Work in this area is centered on adjuvant mitotane and combination treatment approaches for patients with aggressive adrenal malignancy.
Melanoma Immunotherapy
The sponsor supports clinical research in cutaneous malignant melanoma, focusing on treatment after radical surgery in patients with advanced-stage disease.
- Cutaneous malignant melanoma
- Immunotherapy
- Stage IIb-c, III and IV melanoma
Clinical interest extends to the duration of adjuvant immunotherapy in high-risk melanoma following definitive surgical management.
Type 1 Diabetes
Trials also address diabetes type I, with attention to pancreatic islet transplantation as a therapeutic option for restoring insulin production in adults.
- Type 1 diabetes
- Pancreatic islet transplantation
- Immune suppression avoidance
This area reflects interest in cell-based approaches for endocrine replacement therapy and immune-compatible transplantation strategies.
